… (DSC-MRI) in patients with high-grade glioma (HGG) to map relative cerebral blood volume
(… to highest malignant grade and that this improves prognostic assessment in patients. It is …

… Response Assessment in Neuro-Oncology (RANO) Group proposed new recommendations
for evaluating the treatment response of high-grade gliomas … to evaluate tumor response or …

… response following chemoradiotherapy in glioma patients. A … response map (PRM), was
applied to quantitative MRI maps … criteria for phase II studies of supratentorial malignant glioma…

… glioblastoma, synthetic genetic tracing causally connects cellular and molecular heterogeneity
to therapeutic responses… IDH1 status in patients with high-grade glioma and are hereafter …

… of treatment response in gliomas, which has the potential to improve individualized
patient therapy [28]. … of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9(5):453–61. …

… , functional information from brain mapping and monitoring, … minimally invasive surgical
treatment of glioma. Intraoperative … of patient response for neurofunctional mapping and …

… The operational fluctuation between invasion and proliferation as a working hypothesis in
malignant glioma pathobiology is supported by the finding that tumor recurrence often occurs …

… disease burden and treatment response in individuals with malignant gliomas. Traditional …
maps (functional diffusion maps), and rCBV derived from DSC-MRI parametric response map …

… and allows for intraoperative visualization of malignant glioma tissue via fluorescence-guided …
The new genomic era has made it possible to map individual patient glioma genomes and …

… treatment, “monitoring biomarkers” are measured serially and are required to detect any change
in the extent of glioma infiltration or provide evidence of treatment response (… rCBV maps …